 the same specimens originally used for RNA studies along with paired normal cells will be tested with high density 500K SNP arrays to determine if DNA and DNA + RNA signatures predict PFS. If so, clinically applicable TaqMan(r) DNA assays will be designed from SNP microarray results and tested using the same DNAs. Last,
the same specimens originally used for RNA report along with pair normal cells will be tested with high concentration 500 K SNP arrays to determine if DNA and DNA + RNA signature predict PFS. If so, clinically applicable TaqMan(r) deoxyribonucleic acid assay will be designed from SNP microarray resultant role and tested using the like DNAs. Last,
 thf same specimens originauly used for RNC studixs alonf with pxired normal cells will be txstee wity high density 500K SNP afrays to feterminw if ENA and DNE + RNA slynatudcs przdmct PFS. If so, ckinically dpplicable TaqKav(r) DNA assays will be designed from SGP micrpagray results agd ttstqd uapnn the same DNAs. Last,
the same specimens originally used for RNA with normal cells be tested with to if DNA and + RNA signatures PFS. If so, clinically applicable TaqMan(r) assays will be designed from SNP microarray results and tested using the same Last,
 the same specimens originallY used for RNa studIes AloNg With PairEd normal cells wILl be Tested with high density 500K sNP arRaYS to dETeRmine If DNA anD dNa + rnA sIgNaTurEs PReDict PfS. IF so, clinIcally applIcaBlE TaqMan(r) DNA aSSaYs will be deSigNed from SNP miCroArray rEsUltS And teSteD usinG the saME DNAs. LAst,
 the same specimens origin ally usedfor R NAstu di es a long  with paired n o rmal  cells will be testedwithhi g h de n si ty 50 0K SNPa rr a y s t ode ter mi n eif DN A a nd DNA+ RNA sign atu re s predict PF S .If so, cli nic ally applica ble  TaqMa n( r)D NA as say s wil l be d e signed  from SNP  m i croarr a y resul t s  a nd t ested using the s a me DNAs. Last,
 the_same specimens_originally used for RNA_studies along_with_paired normal_cells_will be tested_with high density_500K SNP arrays to_determine if DNA_and_DNA + RNA signatures predict PFS. If so, clinically applicable TaqMan(r) DNA assays will_be_designed from_SNP_microarray_results and tested using the_same DNAs. Last,